We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK’s NHS Reins in Spending on Branded Medicines
UK’s NHS Reins in Spending on Branded Medicines
November 11, 2013
Manufacturers of branded drugs will see their prices capped for the first time beginning Jan. 1, under a new pricing scheme adopted by the UK’s National Health Service.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor